Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study

INTRODUCTION: This study assessed the safety and efficacy of ertugliflozin (an oral sodium-glucose cotransporter 2 inhibitor) vs. glimepiride in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin. METHODS: This phase III, double-blind, non-inferiority study (NCT019992...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Ther
Главные авторы: Hollander, Priscilla, Liu, Jie, Hill, Julie, Johnson, Jeremy, Jiang, Zhi Wei, Golm, Gregory, Huyck, Susan, Terra, Steven G., Mancuso, James P., Engel, Samuel S., Lauring, Brett
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Healthcare 2017
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5801240/
https://ncbi.nlm.nih.gov/pubmed/29282633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0354-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы